拜恩泰科

最新新闻

• 评级变动
  A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $135 to $140
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  BMO Capital Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $128
  \u5e02\u573a\u8d44\u8baf · 2026/8/29
• 评级变动
  Citi Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $125
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• 评级变动
  CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $142
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• 评级变动
  BMO Capital Downgrades BioNTech(BNTX.US) to Hold Rating, Cuts Target Price to $105
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $114
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  Goldman Sachs Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $127
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• 评级变动
  BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $122
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $140
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• 评级变动
  Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $138
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• 评级变动
  UBS Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $135
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $114
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• Argus Research Initiates BioNTech(BNTX.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $136
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• 评级变动
  CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $136
  \u5e02\u573a\u8d44\u8baf · 2026/10/6
• 评级变动
  J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• BioNTech(BNTX.US) 10% Shareholder Sells US$5.95 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/10/10
• Berenberg Bank Initiates BioNTech(BNTX.US) With Buy Rating, Announces Target Price $140
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Wells Fargo Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $140
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $115
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• BioNTech(BNTX.US) 10% Shareholder Sells US$6.48 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• BioNTech(BNTX.US) 10% Shareholder Sells US$6.84 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $115
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• 评级变动
  Evercore Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $130
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• BioNTech(BNTX.US) 10% Shareholder Sells US$6.01 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/29

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。